News
Tuesday, November 6th, 2018
Sirona Biochem Begins Proof of Efficacy Clinical Trial for TFC-1067
Wednesday, October 17th, 2018
Sirona Biochem Engages Consultant for Japanese Market Penetration
Thursday, October 11th, 2018
Sirona Biochem to Present at the 2018 Arctic Circle Assembly
Friday, September 28th, 2018
Sirona Biochem CEO’s Report on Progress
Wednesday, September 26th, 2018
Sirona Biochem Receives Positive Safety Data for Lead Skin-Lightener in Preparation for Clinical Trial in the US
Tuesday, August 28th, 2018
Sirona Biochem Receives $500,000 USD Milestone Payment from Wanbang Biopharmaceuticals
Thursday, July 12th, 2018
Sirona Biochem Announces CFDA Approval of SGLT2 Inhibitor for Phase I Clinical Trial
Monday, April 30th, 2018
Sirona Biochem to Exhibit at the Shanghai China Beauty Expo 2018
Friday, February 2nd, 2018
Sirona Biochem Announces Chief Scientific Officer to Present at Adaptations in Polar Environments and Biomimicry
Wednesday, January 31st, 2018
Sirona Biochem Announces Development of Anti-Wrinkle Treatment and Update from J.P. Morgan Healthcare Conference
Product Development
While carbohydrate-based molecules offer immense commercial potential, we are focusing on three programs at this time.
Social Links Sidebar